Nifuroxazide boosts the anticancer efficacy of palbociclib-induced senescence by dual inhibition of STAT3 and CDK2 in triple-negative breast cancer.

Wang, Xianzhe; Shi, Wei; Wang, Xumei; Lu, Jin-Jian; He, Ping; Zhang, Hongjie; Chen, Xiuping.

Afiliación

Wang X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Shi W; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Wang X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
Lu JJ; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China.
He P; Department of Pharmacology, School of Pharmacy, Guangxi Medical University, Nanning, Guangxi, China.
Zhang H; Biological Imaging and Stem Cell Core, Faculty of Health Sciences, University of Macau, Taipa, Macao, China.
Chen X; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China. xpchen@um.edu.mo.

Cell Death Discov ; 9(1): 355, 2023 Sep 26.

Article en En | MEDLINE | ID: mdl-37752122

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cell Death Discov Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cell Death Discov Año: 2023 Tipo del documento: Article